This is a randomized, controlled, parallel study to determine the efficiency of oral antibiotics in reduction of surgical site infection (SSI) in rectal cancer surgery.
Patients undergoing rectal cancer surgery in a single centre will assigned randomly to combined preoperative oral antibiotics (metronidazole and erythromycin) and perioperative intravenous antibiotics (cefmetazole) (oral+intravenous group) or to perioperative intravenous antibiotics (cefmetazole) alone (intravenous group). The primary endpoint is the overall rate of SSI.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
280
Metronidazole - 500 mg and Erythromycin - 500 mg per os \*3 times at 5 p.m.; 8 p.m., 11 p.m. in a day before surgery
Cefoperazone - 1000 mg intravenously for 30-90 minutes before surgery
Beginning of MBP at 4 p.m. in a day before surgery
State Scientific Centre of Coloproctology
Moscow, Russia
RECRUITINGRate of Surgical Site Infection
Time frame: 0 to 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.